Fingolimod Capsule
Product Images NDC 62756-064

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 62756-064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure diagram of Fingolimod, showing its molecular connectivity with labeled functional groups such as hydroxyl (OH), ammonium chloride (NH3+ Cl-), and aromatic phenyl ring, consistent with the active ingredient Fingolimod.*

FDA Label Image

Figure-1 (Figure 1)

A Kaplan-Meier curve showing the percentage of patients with three-month confirmed progression over time in days. The graph compares two groups: Fingolimod 0.5 mg (solid line) and placebo (dashed line), with percentages reaching approximately 18% for Fingolimod and 24% for placebo by day 720.*

FDA Label Image

14 (Spl 14 Carton)

Fingolimod Capsules 0.5 mg oral unit-dose package label from Sun Pharmaceutical Industries, Inc. The label shows dosage strength, NDC 62756-064-96, package contains 28 unit-dose capsules (2 x 14). Storage and handling instructions, manufacturer details in Gujarat, India, and a medication guide URL are included.*

FDA Label Image

7 (Spl 1x7 Carton)

Fingolimod Capsules 0.5 mg oral capsule unit-dose carton by Sun Pharmaceutical Industries, Inc. The package contains 7 unit-dose capsules, a one-week supply. The label includes storage instructions, child-resistant packaging warning, barcode, NDC 62756-064-59, and manufacturer information from Sun Pharmaceutical Industries Ltd., India.*

FDA Label Image

30 (Spl 30 Label)

Fingolimod Capsules 0.5 mg label showing dosage strength and packaging details. The label includes storage instructions, dosage guidance, and a warning to keep out of reach of children. It states the product contains 0.56 mg fingolimod hydrochloride USP equivalent to 0.5 mg fingolimod per capsule. Manufactured by Sun Pharmaceutical Industries Ltd., distributed by Sun Pharmaceutical Industries, Inc., with a package size of 30 capsules.*

FDA Label Image

25 (Spl 4x7 Carton)

Fingolimod Capsules 0.5 mg oral unit-dose packaging label by Sun Pharmaceutical Industries, Inc. The label states the package contains 28 capsules (4 x 7) providing a four-week supply. Storage instructions and manufacturer details from Sun Pharmaceutical Industries Ltd., Gujarat, India, are included along with barcode and medication guide information.*

FDA Label Image

90 (Spl 90 Label)

Fingolimod Capsules 0.5 mg oral dosage form packaging label. The label indicates each capsule contains 0.5 mg fingolimod, with 90 capsules per package. Manufactured by Sun Pharmaceutical Industries Ltd. in India and distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ. Storage instructions and a medication guide URL are also noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.